A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

What can the pharma industry do about the glass ceiling in women’s careers?

Exploring the ins and outs of a recent UK-based collaboration between two prominent advanced medicine players

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.

Researchers develop a new approach to mapping the individual heterogeneity of brain changes in mental disorders

In vivo animal models have brought much to the science behind the drug development industry, but how far behind are organ-on-a-chip models?

Intellegens CEO Ben Pellegrini explains how machine learning is set to change the oligonucleotide manufacturing landscape

It’s official: CRISPR medicines are here as UK authorizes exa-cel.